Back to top

Promising Preclinical Results for ATNM-400 Drive Buy Rating for Actinium Pharmaceuticals

Analyst Justin Walsh from JonesTrading reiterated a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report) and keeping the price target at...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Actinium Pharmaceuticals, Inc. (ATNM)